Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Surge to $2.14 Billion by 2033, Driven by Innovations, Share Insights, and Rising Global Demand

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $2.14 billion In 2028 At A CAGR Of 6.1% :

The benign prostatic hyperplasia (bph) treatment devices and equipment market size has grown strongly in recent years. It will grow from $1.58 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to aging population, awareness and diagnosis, healthcare access, personalized treatment.

The benign prostatic hyperplasia (bph) treatment devices and equipment market size is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to minimally invasive techniques, emerging markets growth, regulatory support, value-based healthcare. Major trends in the forecast period include non-surgical and office-based procedures, laser and radiofrequency technologies, telemedicine and remote consultation, patient education and engagement.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Major Segments
The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented -

1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

Key Driver - Rising Prevalence Of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) also called Prostate Gland Enlargement (PGE), is a condition where the patient suffers from uncomfortable urinary symptoms. Due to the rising prevalence of Benign Prostatic Hyperplasia (BPH), demand for the BPH treatment devices and equipment is on a steady rise as the number of BPH cases increases the demand for devices will also increase. For example, in 2021, more than 14 million men in the United States have symptoms of BPH. Globally 30 million men have symptoms related to BPH. Therefore, with the number of BPH cases on the steady rise, the demand for BPH treatment devices and equipment is also expected to grow.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=2431&type=smp

Prominent Trend - Innovations In Benign Prostatic Hyperplasia (BPH) Market With Prostatic Artery Embolization (PAE)

Prostatic Artery Embolization (PAE) is one of the latest developments in the market for Benign Prostatic Hyperplasia (BPH) treatment devices and equipment. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in the urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complications in the treatment of BPH and thus is said to be a major development in the market of BPH treatment. Leading companies such as Boston scientific, UNC healthcare, and Spire healthcare have been investing in the market for PAE

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Players
Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report Structure
3. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends And Strategies
4. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market - Macro Economic Scenario
5. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size And Growth
…..
27. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.